Scalper1 News
Big pharma Bristol-Myers Squibb (BMY) reported a quarter of shrinking sales and earnings that still beat analysts’ expectations, sending shares up 2% in early afternoon trading in the stock market today. Bristol-Myers’ Q3 earnings slipped 2% from the year-earlier quarter to 45 cents a share, beating estimates by 3 cents. Sales dropped 4% to $3.9 billion, though Bristol noted that excluding the diabetes business it sold off to AstraZeneca (AZN) Scalper1 News
Scalper1 News